Skip to main content

Schizophrenia & Psychotic Disorders

May 28, 2020
A “small but important” number of people will develop COVID-19–related psychosis, according to a rapid review published online in Schizophrenia Research.
May 19, 2020
Patients who switched from risperidone to lurasidone experienced reductions in several adverse effects, proportionate to increases experienced while on risperidone, according to a study in BMC Psychiatry.
April 21, 2020
Patients with an acute exacerbation of schizophrenia who received an investigational antipsychotic drug had significantly greater improvement in the PANSS total score, compared with those who received placebo, according to a published study.
March 12, 2020
An analysis of brain scans from more than 300 patients suggests two distinct neuroanatomical subtypes of schizophrenia. Researchers published the findings online in the journal Brain.
March 04, 2020
Sustained use of the antipsychotic olanzapine in patients with remitted psychotic depression was associated with a thinning of the cortex, when compared with placebo, according to a study published online in JAMA Psychiatry.
February 27, 2020
Early intervention in schizophrenia may not actually slow or stop a patient’s mental decline, despite a common belief that it will, researchers reported in The American Journal of Psychiatry online.
February 05, 2020
Successfully treating reduced motivation, or avolition, in patients with schizophrenia has a positive effect on other negative symptoms, according to a study published online in Schizophrenia Bulletin.
January 29, 2020
The US Food and Drug Administration (FDA) has accepted Alkermes’ New Drug Application (NDA) for ALKS 3831, a combination of olanzapine and samidorphan, the company announced.
January 22, 2020
Long-term use of antipsychotics by patients with schizophrenia does not increase the risk of hospitalization for comorbid conditions—and is actually associated with substantially decreased mortality, according to a study in World Psychiatry.
January 14, 2020
Having a dog in the household during childhood may significantly decrease the risk of schizophrenia later in life, suggests a study published online in PLOS One.
Back to Top